278 related articles for article (PubMed ID: 12016479)
41. Role of intraoperative thermoablation combined with resection in the treatment of hepatic metastasis from colorectal cancer.
Kornprat P; Jarnagin WR; DeMatteo RP; Fong Y; Blumgart LH; D'Angelica M
Arch Surg; 2007 Nov; 142(11):1087-92. PubMed ID: 18025338
[TBL] [Abstract][Full Text] [Related]
42. Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases.
Hur H; Ko YT; Min BS; Kim KS; Choi JS; Sohn SK; Cho CH; Ko HK; Lee JT; Kim NK
Am J Surg; 2009 Jun; 197(6):728-36. PubMed ID: 18789428
[TBL] [Abstract][Full Text] [Related]
43. [Local recurrence following hepatic radiofrequency ablation: diagnosis and treatment].
Eisele RM; Schumacher G; Neuhaus P
Strahlenther Onkol; 2008 Nov; 184(11):598-604. PubMed ID: 19016019
[TBL] [Abstract][Full Text] [Related]
44. Clinical scenarios associated with local recurrence after laparoscopic radiofrequency thermal ablation of colorectal liver metastases.
Aksoy E; Aliyev S; Taskin HE; Birsen O; Mitchell J; Siperstein A; Berber E
Surgery; 2013 Oct; 154(4):748-52; discussion 752-4. PubMed ID: 24074411
[TBL] [Abstract][Full Text] [Related]
45. Radiofrequency ablation of colorectal liver metastases: mid-term results in 68 patients.
Jakobs TF; Hoffmann RT; Trumm C; Reiser MF; Helmberger TK
Anticancer Res; 2006; 26(1B):671-80. PubMed ID: 16739337
[TBL] [Abstract][Full Text] [Related]
46. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases.
Oshowo A; Gillams A; Harrison E; Lees WR; Taylor I
Br J Surg; 2003 Oct; 90(10):1240-3. PubMed ID: 14515293
[TBL] [Abstract][Full Text] [Related]
47. [Combined liver resection and radiofrequency ablation for colorectal liver metastases].
Kannerup AS; Nielsen DT; Sørensen SM; Mortensen FV
Ugeskr Laeger; 2008 Apr; 170(16):1338-41. PubMed ID: 18433593
[TBL] [Abstract][Full Text] [Related]
48. Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver.
Chung MH; Pisegna J; Spirt M; Giuliano AE; Ye W; Ramming KP; Bilchik AJ
Surgery; 2001 Dec; 130(6):954-62. PubMed ID: 11742323
[TBL] [Abstract][Full Text] [Related]
49. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.
Chambers AJ; Pasieka JL; Dixon E; Rorstad O
Surgery; 2008 Oct; 144(4):645-51; discussion 651-3. PubMed ID: 18847650
[TBL] [Abstract][Full Text] [Related]
50. Radio-frequency ablation of large, nonresectable hepatic tumors.
Morgan JH; Royer GM; Hackett P; Gamblin TC; McCampbell BL; Conforti A; Dale PS
Am Surg; 2004 Dec; 70(12):1035-8. PubMed ID: 15663040
[TBL] [Abstract][Full Text] [Related]
51. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival.
van Vilsteren FG; Baskin-Bey ES; Nagorney DM; Sanderson SO; Kremers WK; Rosen CB; Gores GJ; Hobday TJ
Liver Transpl; 2006 Mar; 12(3):448-56. PubMed ID: 16498656
[TBL] [Abstract][Full Text] [Related]
52. [Radiofrequency ablation for hepatocellular carcinoma and liver metastases].
Yasumoto T; Murakami T; Katsumoto Y; Hashimoto T; Noda S; Murata K; Kinuta M; Nakamura H
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1596-9. PubMed ID: 16315881
[TBL] [Abstract][Full Text] [Related]
53. Radiofrequency ablation for metachronous hepatic metastases from gastric cancer.
Kim HO; Hwang SI; Hong HP; Yoo CH
Surg Laparosc Endosc Percutan Tech; 2009 Jun; 19(3):208-12. PubMed ID: 19542847
[TBL] [Abstract][Full Text] [Related]
54. Outcomes of laparoscopic tumor ablation for neuroendocrine liver metastases: a 20-year experience.
Kose E; Kahramangil B; Aydin H; Donmez M; Takahashi H; Aucejo F; Siperstein A; Berber E
Surg Endosc; 2020 Jan; 34(1):249-256. PubMed ID: 30945061
[TBL] [Abstract][Full Text] [Related]
55. Radiofrequency ablation of hepatic metastases after curative resection of extrahepatic cholangiocarcinoma.
Park SY; Kim JH; Won HJ; Shin YM; Kim PN
AJR Am J Roentgenol; 2011 Dec; 197(6):W1129-34. PubMed ID: 22109330
[TBL] [Abstract][Full Text] [Related]
56. A rational approach to the use of hepatic transplantation in the treatment of metastatic neuroendocrine tumors.
Curtiss SI; Mor E; Schwartz ME; Sung MW; Hytiroglou P; Thung SN; Sheiner PA; Emre S; Miller CM
J Am Coll Surg; 1995 Feb; 180(2):184-7. PubMed ID: 7850052
[TBL] [Abstract][Full Text] [Related]
57. Highly aggressive policy of hepatic resections for neuroendocrine liver metastases.
Grazi GL; Cescon M; Pierangeli F; Ercolani G; Gardini A; Cavallari A; Mazziotti A
Hepatogastroenterology; 2000; 47(32):481-6. PubMed ID: 10791218
[TBL] [Abstract][Full Text] [Related]
58. Surgical management of liver metastases from gastrointestinal endocrine tumors.
Boleslawski E; Dharancy S; Truant S; Pruvot FR
Gastroenterol Clin Biol; 2010; 34(4-5):274-82. PubMed ID: 20347242
[TBL] [Abstract][Full Text] [Related]
59. Feasibility study of two-stage hepatectomy for bilobar liver metastases.
Bowers KA; O'Reilly D; Bond-Smith GE; Hutchins RR
Am J Surg; 2012 Jun; 203(6):691-7. PubMed ID: 22154136
[TBL] [Abstract][Full Text] [Related]
60. Cryosurgery causes a profound reduction in tumor markers in hepatoma and noncolorectal hepatic metastases.
Bilchik AJ; Sarantou T; Wardlaw JC; Ramming KP
Am Surg; 1997 Sep; 63(9):796-800. PubMed ID: 9290524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
